MASK 2017: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma multimorbidity using real-world-evidence

Carregando...
Imagem de Miniatura
Citações na Scopus
109
Tipo de produção
article
Data de publicação
2018
Título da Revista
ISSN da Revista
Título do Volume
Editora
BMC
Autores
BOUSQUET, J.
ARNAVIELHE, S.
BEDBROOK, A.
BEWICK, M.
LAUNE, D.
MATHIEU-DUPAS, E.
MURRAY, R.
ONORATO, G. L.
PEPIN, J. L.
PICARD, R.
Citação
CLINICAL AND TRANSLATIONAL ALLERGY, v.8, article ID 45, 21p, 2018
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
mHealth, such as apps running on consumer smart devices is becoming increasingly popular and has the potential to profoundly affect healthcare and health outcomes. However, it may be disruptive and results achieved are not always reaching the goals. Allergic Rhinitis and its Impact on Asthma (ARIA) has evolved from a guideline using the best evidence-based approach to care pathways suited to real-life using mobile technology in allergic rhinitis (AR) and asthma multimorbidity. Patients largely use over-the-counter medications dispensed in pharmacies. Shared decision making centered around the patient and based on self-management should be the norm. Mobile Airways Sentinel networK (MASK), the Phase 3 ARIA initiative, is based on the freely available MASK app (the Allergy Diary, Android and iOS platforms). MASK is available in 16 languages and deployed in 23 countries. The present paper provides an overview of the methods used in MASK and the key results obtained to date. These include a novel phenotypic characterization of the patients, confirmation of the impact of allergic rhinitis on work productivity and treatment patterns in real life. Most patients appear to self-medicate, are often non-adherent and do not follow guidelines. Moreover, the Allergy Diary is able to distinguish between AR medications. The potential usefulness of MASK will be further explored by POLLAR (Impact of Air Pollution on Asthma and Rhinitis), a new Horizon 2020 project using the Allergy Diary.
Palavras-chave
App, ARIA, Asthma, Care pathways, MASK, mHealth, Rhinitis
Referências
  1. Aldeen YAAS, 2015, SPRINGERPLUS, V4, DOI 10.1186/s40064-015-1481-x
  2. Aristodimou A, 2016, HEALTHC TECHNOL LETT, V3, P16, DOI 10.1049/htl.2015.0050
  3. Azevedo P, 2013, PRIM CARE RESP J, V22, P112, DOI 10.4104/pcrj.2013.00012
  4. BLAND JM, 1986, LANCET, V1, P307
  5. Bourret Rodolphe, 2015, World Hosp Health Serv, V51, P36
  6. Bousquet J, 2008, ALLERGY, V63, P8, DOI 10.1111/j.1398-9995.2007.01620.x
  7. Bousquet J, 2018, ALLERGY, V73, P1622, DOI 10.1111/all.13448
  8. Bousquet J, 2018, ALLERGY, V73, P1763, DOI 10.1111/all.13406
  9. Bousquet J, 2018, J INVEST ALLERG CLIN, V28, P42, DOI 10.18176/jiaci.0197
  10. Bousquet J, 2018, ALLERGY, V73, P77, DOI 10.1111/all.13218
  11. Bousquet J, 2017, CLIN TRANSL ALLERGY, V7, DOI 10.1186/s13601-017-0173-8
  12. Bousquet J, 2017, ALLERGY, V72, P1475, DOI 10.1111/all.13177
  13. Bousquet J, 2017, ALLERGY, V72, P1261, DOI 10.1111/all.13137
  14. Bousquet J, 2017, ALLERGY, V72, P857, DOI 10.1111/all.13125
  15. Bousquet J, 2016, CLIN TRANSL ALLERGY, V6, DOI 10.1186/s13601-016-0137-4
  16. Bousquet J, 2016, CLIN TRANSL ALLERGY, V6, DOI 10.1186/s13601-016-0116-9
  17. Bousquet J, 2016, REV PORT PNEUMOL, V22, P1, DOI 10.1016/j.rppnen.2015.12.006
  18. Bousquet J, 2015, ALLERGY, V70, P1372, DOI 10.1111/all.12686
  19. Bousquet J, 2014, EUR RESPIR J, V44, P304, DOI 10.1183/09031936.00014614
  20. Bousquet J, 2004, ALLERGY, V59, P373
  21. Bousquet J, 2001, J ALLERGY CLIN IMMUN, V108, pS147, DOI 10.1067/mai.2001.118891
  22. Bousquet J, 2017, J ALLERGY CLIN IMMUN, V140, P891, DOI 10.1016/j.jaci.2017.04.042
  23. Bousquet J, 2017, EUR RESPIR J, V49, DOI 10.1183/13993003.00447-2017
  24. Bousquet J, 2016, J ALLERGY CLIN IMMUN, V138, P367, DOI 10.1016/j.jaci.2016.03.025
  25. Bousquet J, 2010, J ALLERGY CLIN IMMUN, V126, P926, DOI 10.1016/j.jaci.2010.07.019
  26. Bousquet J, 2009, J ALLERGY CLIN IMMUN, V124, P428, DOI 10.1016/j.jaci.2009.06.027
  27. Brozek JL, 2017, J ALLERGY CLIN IMMUN, V140, P950, DOI 10.1016/j.jaci.2017.03.050
  28. Brozek JL, 2010, J ALLERGY CLIN IMMUN, V126, P466, DOI 10.1016/j.jaci.2010.06.047
  29. Caimmi D, 2017, CLIN EXP ALLERGY, V47, P1526, DOI 10.1111/cea.13025
  30. Carr WW, 2017, POSTGRAD MED, V129, P572, DOI 10.1080/00325481.2017.1333384
  31. Cingi C, 2017, CLIN TRANSL ALLERGY, V7, DOI 10.1186/s13601-017-0153-z
  32. De Greve G, 2017, CLIN TRANSL ALLERGY, V7, DOI 10.1186/s13601-017-0157-8
  33. Devillier P, 2014, ALLERGY, V69, P1689, DOI 10.1111/all.12518
  34. El Emam K, 2009, J AM MED INFORM ASSN, V16, P670, DOI 10.1197/jamia.M3144
  35. Fonseca JA, 2010, ALLERGY, V65, P1042, DOI 10.1111/j.1398-9995.2009.02310.x
  36. Freifeld CC, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000376
  37. Frohlich M, 2017, CLIN TRANSL ALLERGY, V7, DOI 10.1186/s13601-017-0176-5
  38. Geryk LL, 2016, JMIR RES PROTOC, V5, DOI 10.2196/resprot.5932
  39. Hellings PW, 2017, ALLERGY, V72, P1297, DOI 10.1111/all.13162
  40. Hellings PW, 2013, ALLERGY, V68, P1, DOI 10.1111/all.12040
  41. Hellings PW, 2015, CLIN TRANSL ALLERGY, V5, DOI 10.1186/s13601-015-0080-9
  42. JOHNS MW, 1992, SLEEP, V15, P376, DOI 10.1093/sleep/15.4.376
  43. Keijser W, 2016, J NUTR HEALTH AGING, V20, P1024, DOI 10.1007/s12603-016-0804-0
  44. Konig HH, 2009, MED CARE, V47, P255, DOI 10.1097/MLR.0b013e318184759e
  45. KOPPKUBEL S, 1995, B WORLD HEALTH ORGAN, V73, P275
  46. Lau AYS, 2015, J MED INTERNET RES, V17, DOI 10.2196/jmir.4734
  47. Lee L, 2016, STUD HEALTH TECHNOL, V222, P53, DOI 10.3233/978-1-61499-635-4-53
  48. Leger D, 2006, ARCH INTERN MED, V166, P1744, DOI 10.1001/archinte.166.16.1744
  49. Lombardi Carlo, 2015, Asthma Res Pract, V1, P4
  50. mHealth, 2011, GLOBAL OBSERVATORY E, V3
  51. Mokkink LB, 2010, J CLIN EPIDEMIOL, V63, P737, DOI 10.1016/j.jclinepi.2010.02.006
  52. Mozaffar H, 2017, BMJ QUAL SAF, V26, P722, DOI 10.1136/bmjqs-2016-005879
  53. Nogueira-Silva L, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-52
  54. Onder G, 2015, EUR J INTERN MED, V26, P157, DOI 10.1016/j.ejim.2015.02.020
  55. Ozdalga E, 2012, J MED INTERNET RES, V14, DOI 10.2196/jmir.1994
  56. Samreth D, 2018, WORLD ALLERGY ORGAN, V11, DOI 10.1186/s40413-018-0194-3
  57. Santo K, 2016, JMIR MHEALTH UHEALTH, V4, DOI 10.2196/mhealth.6742
  58. Simpson AJ, 2017, EUR RESPIR J, V49, DOI 10.1183/13993003.01966-2016
  59. Smith AF, 2005, OPHTHAL EPIDEMIOL, V12, P233, DOI 10.1080/09286580590967781
  60. Sweeney L, 2002, INT J UNCERTAIN FUZZ, V10, P557, DOI 10.1142/S0218488502001648
  61. Talboom-Kamp EPWA, 2016, INTERACT J MED RES, V5, P21, DOI 10.2196/ijmr.4217
  62. Tan R, 2017, ASTHMA RES PRACT, V3, P8, DOI 10.1186/S40733-017-0036-Z
  63. Thakkar J, 2016, JAMA INTERN MED, V176, P340, DOI 10.1001/jamainternmed.2015.7667
  64. van der Leeuw S, 2015, NPJ PRIM CARE RESP M, V25, DOI 10.1038/npjpcrm.2014.107
  65. Vandenplas O, 2018, J ALLER CL IMM-PRACT, V6, P1274, DOI 10.1016/j.jaip.2017.09.002
  66. Wustenberg E, 2017, ALLERGO J, V26, P14